Amgen Inc. (Nasdaq: AMGN) is up 8 percent in pre-open trading today following positive Denosumab survival ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE